Submit Content
Get the latest delivered to your inbox
Privacy Policy

Alkermes

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

    Alkermes Supporting Local Communities Image

    POSTED 

    11-29-22

    Alkermes Supporting Local Communities

    Alkermes respects the culture, customs and values of the people in the communities in which we operate. We seek to support and positively impact these communities through our grant programs, sponsorship contributions and volunteer support.
    Alkermes Announces Recipients of 2022 Alkermes Inspiration Grants® Program Image

    POSTED 

    11-08-22

    Alkermes Announces Recipients of 2022 Alkermes Inspiration Grants® Program

    Alkermes plc (Nasdaq: ALKS) announced the 2022 recipients of the Alkermes Inspiration Grants® program.
    Tips for Managing a Multigenerational, Post-Pandemic Workforce Image

    POSTED 

    09-30-22

    Tips for Managing a Multigenerational, Post-Pandemic Workforce

    Check out Alkermes’ Steve Schiavo, SVP of HR, in this BioSpace article discussing how to best support a multigenerational workforce
    Alkermes Earns 2022 Best Place for Working Parents Designation Image

    POSTED 

    08-17-22

    Alkermes Earns 2022 Best Place for Working Parents Designation

    For the all the working parents at Alkermes, we recognize that there is no greater responsibility than being present for your family.
    About the Alkermes Inspiration Grants® Program Image

    POSTED 

    07-15-22

    About the Alkermes Inspiration Grants® Program

    Organizations supporting people living with addiction, serious mental illness and cancer have faced unique needs and challenges during the COVID pandemic.
    LGB Adults Are More Likely to Binge Drink Than Their Non-LGB Counterparts Image

    POSTED 

    06-24-22

    LGB Adults Are More Likely to Binge Drink Than Their Non-LGB Counterparts

    A survey by the The National Institute on Drug Abuse (NIDA) showed that 32% of lesbian, gay and bisexual adults reported binge drinking versus 26% of non-LGB adults.
    Celebrating LGBTQIA+ Mental Health Trailblazers Image

    POSTED 

    06-15-22

    Celebrating LGBTQIA+ Mental Health Trailblazers

    Pride Month is a time for us to celebrate the important strides made to support and advance LGBTQIA+ mental health.
    Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer Image

    POSTED 

    06-07-22

    Alkermes Announces 2022 Alkermes Inspiration Grants® Program to Support Innovative Programs Focused on People Affected by Addiction, Serious Mental Illness or Cancer

    Alkermes plc (Nasdaq: ALKS) announced that the company will accept applications for its Alkermes Inspiration Grants® program beginning on June 15, 2022.
    Substance Use Disorders Impacted 8.3% of American Adults in 2020 Image

    POSTED 

    06-02-22

    Substance Use Disorders Impacted 8.3% of American Adults in 2020

    The 2020 National Survey on Drug Use and Health reports that 8.3% of American adults, or 20.9 million people, in the United States had a substance use disorder in 2020.
     Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health Image

    POSTED 

    05-20-22

    Alkermes Awarded 2022 Platinum Bell Seal for Workplace Mental Health

    We’re proud to announce that we’ve received the 2022 #BellSealforWorkplaceMentalHealth at Platinum from Mental Health America!
    Alkermes logo

    Alkermes

    Alkermes

    Join today and get the latest delivered to your inbox